In their in vivo experiment, Gu et al. [39] found lipid-reducing activity in a diet-induced obesity NAFLD model in mice that was mediated by FXR selective activation in hepatic tissue. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.